Abstract:BACKGROUND: With the progress of the mid-term and long-term follow-up study, it is found that the periprosthesis loosening is an important factor that limits the service life of artificial prosthesis and restricts the development of artificial joint replacement. OBJECTIVE: To further understand the Wnt/β-catenin signaling pathway and provide new targets for drug therapy by analyzing the research results of main signal factors of Wnt/β-catenin signaling pathway on osteoblasts and the cell function of osteoblast origin. METHODS: The first author searched the literature published from 2005 to 2020 by computer with the Chinese key words of “wear debris, peri-prosthetic osteolysis, aseptic loosening, pathogenesis, osteoblast, signaling pathway, bone remodeling, Wnt/β-catenin” in the databases of CNKI, Wanfang and VIP, and with the English key words of “wear debris, wear particles, peri-prosthetic osteolysis, PPO, aseptic loosening, AL, pathogenesis, osteoblast, OB, signal path, bone remodeling, Wnt/β-catenin” in PubMed and Web of Science. The articles regarding the effect and mechanism of Wnt/β-catenin pathway on osteoblasts under the influence of wear particles were collected. Finally, 53 articles were included according to the inclusion and exclusion criteria. RESULTS AND CONCLUSION: (1) During the pathological process of wear particle induced osteolysis around implant and aseptic loosening, Wnt/β-catenin signaling pathways activated by inhibiting bone-forming formation and increasing bone resorption, in turn, affects bone reconstruction, and has played a key role in the pathology of wear particle induced osteolysis around implant and aseptic loosening. (2) In vitro experiments, Wnt/β-catenin signaling pathways were activated by GSK-3β inhibitor LiCl, growth hormone release polypeptide, and protein phosphatase 2A inhibition to promote osteoblast differentiation and osteogenic activity. However, ICG-001 inhibitor blocked the β-catenin signaling pathway, thus weakening the protective effect of LiCl on osteoblastic differentiation, suggesting that GSK-3/β-catenin signaling pathway may be an important mechanism mediating Ti wear particles to induce osteolysis around the prosthesis. (3) In vivo experiments, the application of SOST antibody, protein phosphatase 2A inhibition, LiCl, AR28 and other ways through activation of Wnt/β-catenin and other signal pathways can promote bone formation, inhibit osteoclast absorption, increase local bone mass and bone volume, and resist the effect of osteolysis around the prosthesis induced by Ti and other wear particles. (4) At the gene level, the activity and mineralization of MC3T3-E1 cells were also significantly enhanced under SOST silencing condition, even when treated with titanium particles. On the contrary, the decreased expression level of SOST increased the expression level of β-catenin. The results suggested that the decrease of SOST gene expression could activate the Wnt/β-catenin signaling pathway to promote bone formation and improve the bone loss caused by Ti particles.

GSK-3β suppression upregulates Gli1 to alleviate osteogenesis inhibition in titanium nanoparticle-induced osteolysis

Platelet-Derived Growth Factor-Bb Attenuates Titanium-Particle-Induced Osteolysis in Vivo

Titanium Particle-Induced Osteogenic Inhibition and Bone Destruction Are Mediated by the GSK-3β/β-catenin Signal Pathway

Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade.

Pharmaceutical Inhibition of Glycogen Synthetase Kinase 3 Beta Suppresses Wear Debris-Induced Osteolysis.

Protective effects of sirtuin 3 on titanium particle-induced osteogenic inhibition by regulating the NLRP3 inflammasome via the GSK-3β/β-catenin signalling pathway

Protective effects of sirtuin 3 on titanium particle-induced osteogenic inhibition by regulating the NLRP3 inflammasome via the GSK-3/-catenin signalling pathway

Acetyl-11-keto-β-boswellic Acid Attenuates Titanium Particle-Induced Osteogenic Inhibition Via Activation of the GSK-3β/β-catenin Signaling Pathway.

Effect of Wnt/beta-catenin Signaling Pathway on Osteoblasts under the Action of Wear Particles

Inhibition of Protein Phosphatase 2A Attenuates Titanium-Particle Induced Suppression of Bone Formation.

DNA Methylation-Mediated GPX4 Transcriptional Repression and Osteoblast Ferroptosis Promote Titanium Particle-Induced Osteolysis

Osteocytes Exposed to Titanium Particles Inhibit Osteoblastic Cell Differentiation Via Connexin 43.

Gö6983 Attenuates Titanium Particle-Induced Osteolysis and RANKL Mediated Osteoclastogenesis Through the Suppression of NFκB/JNK/p38 Pathways

LY450139 Inhibited Ti-Particle-Induced Bone Dissolution via Suppressing Notch and NF-κB Signaling Pathways

Gö6983 attenuates titanium particle-induced osteolysis and RANKL mediated osteoclastogenesis through the suppression of NFκB/JNK/p38 pathways.

Inhibition of Sirtuin 3 prevents titanium particle-induced bone resorption and osteoclastsogenesis via suppressing ERK and JNK signaling

Stevioside Prevents Wear Particle-Induced Osteolysis by Inhibiting Osteoclastogenesis and Inflammatory Response via the Suppression of TAK1 Activation.

Quercetin Inhibits Titanium Particle-Mediated M1 Macrophage Polarization Through the P-38Α/β Signaling Pathway and Regulate OPG/RANKL Balance in a Mouse Skull Model

SOST Gene Suppression Stimulates Osteocyte Wnt/?-catenin Signaling to Prevent Bone Resorption and Attenuates Particle-Induced Osteolysis

TiAl6V4 Particles Promote Osteoclast Formation Via Autophagy-Mediated Downregulation of Interferon-Beta in Osteocytes

Reduction of SOST Gene Promotes Bone Formation Through the Wnt/β‐catenin Signalling Pathway and Compensates Particle‐induced Osteolysis